Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers

4 May 2021

Abstract excerpt

BACKGROUND: Current risk models for renal cell carcinoma (RCC) based on clinicopathological factors are sub-optimal in accurately identifying high-risk patients. Here, we perform a head-to-head comparison of previously published DNA methylation markers and propose a potential prognostic model for clear cell RCC (ccRCC). PATIENTS AND METHODS: Promoter methylation of PCDH8, BNC1, SCUBE3, GREM1, LAD1, NEFH, RASSF1A,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33947447
DOI: 10.1186/s13148-021-01084-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markersPMID 33947447Read ↗

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer PatientsSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

Construction and Validation of a Prognostic Nomogram for Clear Cell Renal Cell Carcinoma Based on DNA Methylation-driven Differentially Expressed GenesSemantic proximity Read ↗

Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

A CpG-methylation-based assay to predict survival in clear cell renal cell carcinomaSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinomaSemantic proximity Read ↗

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinomaSemantic proximity Read ↗

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic TreatmentsSemantic proximity Read ↗

A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostication of patients with clear cell renal cell carcinomas based on quantification of DNA methylation levels of CpG island methylator phenotype marker genes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.